These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
75 related items for PubMed ID: 3538403
21. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Lipinski B, Wegrzynowicz Z, Budzynski AZ, Kopeć M, Latallo ZS, Kowalski E. Thromb Diath Haemorrh; 1967 Feb 28; 17(1-2):65-77. PubMed ID: 5584961 [No Abstract] [Full Text] [Related]
22. [Relevance of fibrinogen/fibrin degradation products in the study of thrombosis]. Páramo JA, Gaffney PJ. Sangre (Barc); 1989 Dec 28; 34(6):497-501. PubMed ID: 2697948 [No Abstract] [Full Text] [Related]
23. [Hemostatic changes related to anesthetic drugs and surgical intervention]. Sparacia A, Mangione S, Sansone A. Minerva Anestesiol; 1980 Jul 28; 46(7):791-814. PubMed ID: 7017462 [No Abstract] [Full Text] [Related]
24. [Somatostatin and the hemostatic system (author's transl)]. Hnidec O. Przegl Lek; 1980 Jul 28; 37(4):421-3. PubMed ID: 6105700 [No Abstract] [Full Text] [Related]
25. Fibrinogen degradation products do not affect the hypertensive action of dopamine. Buczko W, Wiśniewski K. Acta Med Pol; 1986 Jul 28; 27(1-2):31-6. PubMed ID: 3565076 [No Abstract] [Full Text] [Related]
26. Biological properties of fibrinogen derivatives relevant to the function of cardiovascular system and immuno-inflammatory reaction. Kopec M. New Istanbul Contrib Clin Sci; 1977 Sep 28; 12(1):43-9. PubMed ID: 565049 [No Abstract] [Full Text] [Related]
32. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products. Suzuki A, Ebinuma H, Matsuo M, Miyazaki O, Yago H. Thromb Res; 2007 Feb 23; 121(3):377-85. PubMed ID: 17561232 [Abstract] [Full Text] [Related]
33. [Fibrinogen and fibrin degradation products]. Fujimaki M, Ikematsu S, Kato M. Rinsho Byori; 1973 Jan 23; 21(1):31-6. PubMed ID: 4267650 [No Abstract] [Full Text] [Related]
34. [An analysis of a disorder in the fibrin-forming phase in virtually healthy middle-aged and elderly subjects by using the ancistron test]. Platonova TN, Sushko OO, Lukinova NI, Solovĭov DA. Fiziol Zh (1994); 1994 Jan 23; 40(3-4):63-70. PubMed ID: 7621957 [Abstract] [Full Text] [Related]
35. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats. Nieuwenhuizen W, Emeis JJ, Vermond A. Thromb Haemost; 1982 Aug 24; 48(1):59-61. PubMed ID: 7135343 [Abstract] [Full Text] [Related]
40. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator. Reininger CB, Graf J, Reininger AJ, Spannagl M, Steckmeier B, Schweiberer L. Int Angiol; 1996 Dec 24; 15(4):335-43. PubMed ID: 9127775 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]